Structure

Physi-Chem Properties

Molecular Weight:  242.14
Volume:  259.928
LogP:  1.111
LogD:  1.15
LogS:  -2.665
# Rotatable Bonds:  1
TPSA:  58.88
# H-Bond Aceptor:  3
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.738
Synthetic Accessibility Score:  5.21
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.575
MDCK Permeability:  5.243458417680813e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.973
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.021
30% Bioavailability (F30%):  0.014

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.056
Plasma Protein Binding (PPB):  73.90784454345703%
Volume Distribution (VD):  1.123
Pgp-substrate:  20.794384002685547%

ADMET: Metabolism

CYP1A2-inhibitor:  0.261
CYP1A2-substrate:  0.667
CYP2C19-inhibitor:  0.186
CYP2C19-substrate:  0.176
CYP2C9-inhibitor:  0.115
CYP2C9-substrate:  0.256
CYP2D6-inhibitor:  0.073
CYP2D6-substrate:  0.393
CYP3A4-inhibitor:  0.769
CYP3A4-substrate:  0.376

ADMET: Excretion

Clearance (CL):  3.904
Half-life (T1/2):  0.851

ADMET: Toxicity

hERG Blockers:  0.047
Human Hepatotoxicity (H-HT):  0.321
Drug-inuced Liver Injury (DILI):  0.066
AMES Toxicity:  0.206
Rat Oral Acute Toxicity:  0.728
Maximum Recommended Daily Dose:  0.925
Skin Sensitization:  0.087
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.015
Respiratory Toxicity:  0.915

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC32028

Natural Product ID:  NPC32028
Common Name*:   IZGRHSRWTILCID-FIXISWKDSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  IZGRHSRWTILCID-FIXISWKDSA-N
Standard InCHI:  InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10-11H,1,7-8,16H2,2H3,(H,17,18)/t10-,11+,15+/m0/s1
SMILES:  CC1=C[C@@H]2[C@H]([C@@](C1)(N)c1ccc(nc1C2)O)C=C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409142
PubChem CID:   10198698
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0000056] Quinolones and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32769 lycopodiastrum casuarinoides Species Lycopodiaceae Eukaryota n.a. n.a. n.a. PMID[23941108]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT204 Individual Protein Acetylcholinesterase Homo sapiens IC50 = 489.0 nM PMID[486676]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC32028 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC315214
0.9933 High Similarity NPC47298
0.9867 High Similarity NPC159319
0.9613 High Similarity NPC259545
0.961 High Similarity NPC126481
0.9371 High Similarity NPC232340
0.9241 High Similarity NPC471294
0.8848 High Similarity NPC133306
0.8713 High Similarity NPC45850
0.8588 High Similarity NPC183805
0.8312 Intermediate Similarity NPC60553
0.7988 Intermediate Similarity NPC84508
0.7987 Intermediate Similarity NPC161292
0.7844 Intermediate Similarity NPC473057
0.7803 Intermediate Similarity NPC88363
0.7791 Intermediate Similarity NPC153769
0.7785 Intermediate Similarity NPC245657
0.7753 Intermediate Similarity NPC246700
0.7753 Intermediate Similarity NPC128751
0.7722 Intermediate Similarity NPC280853
0.7709 Intermediate Similarity NPC469497
0.7709 Intermediate Similarity NPC106833
0.7701 Intermediate Similarity NPC72980
0.7697 Intermediate Similarity NPC206186
0.7684 Intermediate Similarity NPC94943
0.7673 Intermediate Similarity NPC285016
0.767 Intermediate Similarity NPC212535
0.7658 Intermediate Similarity NPC471596
0.7627 Intermediate Similarity NPC190007
0.7572 Intermediate Similarity NPC474409
0.7557 Intermediate Similarity NPC478032
0.7547 Intermediate Similarity NPC471594
0.7531 Intermediate Similarity NPC471598
0.7529 Intermediate Similarity NPC97367
0.75 Intermediate Similarity NPC44161
0.7486 Intermediate Similarity NPC288943
0.7485 Intermediate Similarity NPC471178
0.7471 Intermediate Similarity NPC124542
0.7471 Intermediate Similarity NPC471177
0.7471 Intermediate Similarity NPC59779
0.7468 Intermediate Similarity NPC278451
0.7459 Intermediate Similarity NPC153042
0.7455 Intermediate Similarity NPC288445
0.7443 Intermediate Similarity NPC283152
0.744 Intermediate Similarity NPC141353
0.7433 Intermediate Similarity NPC249040
0.7429 Intermediate Similarity NPC303225
0.7425 Intermediate Similarity NPC26872
0.7414 Intermediate Similarity NPC105758
0.7414 Intermediate Similarity NPC476686
0.7414 Intermediate Similarity NPC476688
0.7389 Intermediate Similarity NPC476319
0.7374 Intermediate Similarity NPC19679
0.7366 Intermediate Similarity NPC474188
0.7348 Intermediate Similarity NPC171171
0.7344 Intermediate Similarity NPC477111
0.7337 Intermediate Similarity NPC141915
0.7337 Intermediate Similarity NPC114335
0.7337 Intermediate Similarity NPC280964
0.7333 Intermediate Similarity NPC320394
0.7333 Intermediate Similarity NPC204717
0.7308 Intermediate Similarity NPC66083
0.7299 Intermediate Similarity NPC278874
0.7294 Intermediate Similarity NPC26850
0.7293 Intermediate Similarity NPC314002
0.7278 Intermediate Similarity NPC220765
0.7277 Intermediate Similarity NPC475070
0.7273 Intermediate Similarity NPC70956
0.7273 Intermediate Similarity NPC243834
0.7273 Intermediate Similarity NPC208060
0.7256 Intermediate Similarity NPC470403
0.7256 Intermediate Similarity NPC470404
0.7256 Intermediate Similarity NPC470394
0.7254 Intermediate Similarity NPC470931
0.7254 Intermediate Similarity NPC475910
0.7253 Intermediate Similarity NPC194040
0.7253 Intermediate Similarity NPC314573
0.7249 Intermediate Similarity NPC329747
0.7249 Intermediate Similarity NPC329793
0.7241 Intermediate Similarity NPC98187
0.7241 Intermediate Similarity NPC108469
0.724 Intermediate Similarity NPC477113
0.7238 Intermediate Similarity NPC62069
0.7228 Intermediate Similarity NPC3715
0.7225 Intermediate Similarity NPC223427
0.7216 Intermediate Similarity NPC158129
0.7213 Intermediate Similarity NPC46580
0.7204 Intermediate Similarity NPC329541
0.72 Intermediate Similarity NPC154293
0.7198 Intermediate Similarity NPC42591
0.7173 Intermediate Similarity NPC475112
0.7173 Intermediate Similarity NPC475085
0.7173 Intermediate Similarity NPC291535
0.7172 Intermediate Similarity NPC330009
0.7172 Intermediate Similarity NPC469928
0.7169 Intermediate Similarity NPC470395
0.7168 Intermediate Similarity NPC224632
0.7168 Intermediate Similarity NPC177404
0.7159 Intermediate Similarity NPC473764
0.7159 Intermediate Similarity NPC314940
0.7157 Intermediate Similarity NPC478074
0.7151 Intermediate Similarity NPC324149
0.7151 Intermediate Similarity NPC99666
0.7135 Intermediate Similarity NPC189812
0.7135 Intermediate Similarity NPC329688
0.7135 Intermediate Similarity NPC95783
0.7128 Intermediate Similarity NPC476116
0.7127 Intermediate Similarity NPC144114
0.712 Intermediate Similarity NPC254762
0.7113 Intermediate Similarity NPC193777
0.7111 Intermediate Similarity NPC67659
0.7105 Intermediate Similarity NPC476167
0.7102 Intermediate Similarity NPC317430
0.7088 Intermediate Similarity NPC176127
0.7085 Intermediate Similarity NPC183407
0.7083 Intermediate Similarity NPC257142
0.7081 Intermediate Similarity NPC32771
0.7079 Intermediate Similarity NPC34508
0.7074 Intermediate Similarity NPC276517
0.7069 Intermediate Similarity NPC16667
0.7065 Intermediate Similarity NPC61350
0.7062 Intermediate Similarity NPC280548
0.7056 Intermediate Similarity NPC184964
0.7053 Intermediate Similarity NPC306376
0.7053 Intermediate Similarity NPC192315
0.7049 Intermediate Similarity NPC84478
0.7047 Intermediate Similarity NPC476098
0.7039 Intermediate Similarity NPC312872
0.7037 Intermediate Similarity NPC205403
0.7035 Intermediate Similarity NPC285469
0.7033 Intermediate Similarity NPC314394
0.7033 Intermediate Similarity NPC477891
0.7031 Intermediate Similarity NPC267423
0.7029 Intermediate Similarity NPC118511
0.702 Intermediate Similarity NPC294620
0.702 Intermediate Similarity NPC48353
0.7018 Intermediate Similarity NPC36168
0.7016 Intermediate Similarity NPC128823
0.7011 Intermediate Similarity NPC131718
0.7005 Intermediate Similarity NPC469390
0.7 Intermediate Similarity NPC150048
0.7 Intermediate Similarity NPC77555
0.7 Intermediate Similarity NPC134586
0.7 Intermediate Similarity NPC203754
0.7 Intermediate Similarity NPC477110
0.699 Remote Similarity NPC18348
0.6989 Remote Similarity NPC242928
0.6984 Remote Similarity NPC195314
0.6983 Remote Similarity NPC313791
0.6983 Remote Similarity NPC472123
0.6979 Remote Similarity NPC11017
0.6974 Remote Similarity NPC474145
0.6974 Remote Similarity NPC475841
0.697 Remote Similarity NPC220337
0.697 Remote Similarity NPC9894
0.697 Remote Similarity NPC208284
0.6966 Remote Similarity NPC164664
0.6961 Remote Similarity NPC96890
0.6961 Remote Similarity NPC211997
0.6961 Remote Similarity NPC162748
0.6959 Remote Similarity NPC284348
0.6947 Remote Similarity NPC242209
0.6947 Remote Similarity NPC70259
0.6947 Remote Similarity NPC472193
0.6941 Remote Similarity NPC124005
0.6936 Remote Similarity NPC184476
0.6932 Remote Similarity NPC476118
0.6931 Remote Similarity NPC289786
0.6927 Remote Similarity NPC32200
0.6927 Remote Similarity NPC280714
0.6927 Remote Similarity NPC476175
0.6923 Remote Similarity NPC164374
0.6923 Remote Similarity NPC270009
0.6923 Remote Similarity NPC137929
0.6919 Remote Similarity NPC5145
0.6919 Remote Similarity NPC471304
0.6911 Remote Similarity NPC156704
0.6908 Remote Similarity NPC6215
0.6905 Remote Similarity NPC242556
0.6897 Remote Similarity NPC116573
0.6895 Remote Similarity NPC43787
0.6895 Remote Similarity NPC205934
0.6888 Remote Similarity NPC304183
0.6888 Remote Similarity NPC476106
0.6885 Remote Similarity NPC198339
0.6881 Remote Similarity NPC304926
0.6881 Remote Similarity NPC476041
0.6879 Remote Similarity NPC38736
0.6879 Remote Similarity NPC207726
0.6875 Remote Similarity NPC72211
0.6872 Remote Similarity NPC477135
0.6868 Remote Similarity NPC151939
0.6857 Remote Similarity NPC67056
0.6856 Remote Similarity NPC476044
0.6853 Remote Similarity NPC53344
0.6853 Remote Similarity NPC270918
0.6848 Remote Similarity NPC192270
0.6842 Remote Similarity NPC307963
0.6842 Remote Similarity NPC37548
0.6837 Remote Similarity NPC470500

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC32028 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9933 High Similarity NPD1685 Approved
0.9933 High Similarity NPD1684 Approved
0.8315 Intermediate Similarity NPD5497 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD5522 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD925 Approved
0.7692 Intermediate Similarity NPD926 Approved
0.7683 Intermediate Similarity NPD6158 Phase 2
0.7683 Intermediate Similarity NPD6476 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD1325 Approved
0.7661 Intermediate Similarity NPD1326 Approved
0.7609 Intermediate Similarity NPD7889 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD2882 Phase 1
0.7568 Intermediate Similarity NPD2176 Approved
0.7568 Intermediate Similarity NPD2175 Phase 3
0.7568 Intermediate Similarity NPD2177 Approved
0.7543 Intermediate Similarity NPD6159 Phase 2
0.75 Intermediate Similarity NPD2383 Phase 1
0.7469 Intermediate Similarity NPD3525 Discontinued
0.7442 Intermediate Similarity NPD425 Approved
0.7442 Intermediate Similarity NPD424 Approved
0.7435 Intermediate Similarity NPD2916 Discontinued
0.7416 Intermediate Similarity NPD4204 Approved
0.7416 Intermediate Similarity NPD4203 Approved
0.7414 Intermediate Similarity NPD1078 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD5939 Approved
0.7409 Intermediate Similarity NPD5936 Approved
0.7401 Intermediate Similarity NPD1503 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD4511 Phase 1
0.7351 Intermediate Similarity NPD3810 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD6491 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD863 Approved
0.7326 Intermediate Similarity NPD861 Approved
0.7326 Intermediate Similarity NPD862 Approved
0.7301 Intermediate Similarity NPD1592 Phase 3
0.7293 Intermediate Similarity NPD6344 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD2381 Approved
0.7288 Intermediate Similarity NPD2380 Approved
0.7288 Intermediate Similarity NPD5100 Phase 3
0.7288 Intermediate Similarity NPD2382 Approved
0.7287 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7474 Suspended
0.7251 Intermediate Similarity NPD604 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD5255 Approved
0.7232 Intermediate Similarity NPD6492 Phase 2
0.7232 Intermediate Similarity NPD5065 Approved
0.7225 Intermediate Similarity NPD4044 Discontinued
0.7207 Intermediate Similarity NPD3920 Phase 2
0.7204 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6290 Phase 2
0.72 Intermediate Similarity NPD2781 Approved
0.7193 Intermediate Similarity NPD4669 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4670 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4671 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD4703 Approved
0.7186 Intermediate Similarity NPD4702 Approved
0.7184 Intermediate Similarity NPD2782 Approved
0.7184 Intermediate Similarity NPD2780 Approved
0.7175 Intermediate Similarity NPD7418 Discontinued
0.7165 Intermediate Similarity NPD6376 Discontinued
0.7143 Intermediate Similarity NPD4502 Phase 2
0.7143 Intermediate Similarity NPD2727 Phase 2
0.7143 Intermediate Similarity NPD5083 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD444 Approved
0.7113 Intermediate Similarity NPD3930 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD3417 Phase 1
0.7108 Intermediate Similarity NPD3813 Approved
0.7105 Intermediate Similarity NPD8395 Approved
0.7105 Intermediate Similarity NPD8396 Approved
0.7104 Intermediate Similarity NPD2762 Phase 2
0.7095 Intermediate Similarity NPD6375 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD7948 Phase 1
0.7086 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD3932 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3404 Approved
0.7045 Intermediate Similarity NPD4554 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD7414 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD3814 Phase 1
0.7006 Intermediate Similarity NPD6872 Clinical (unspecified phase)
0.6995 Remote Similarity NPD3928 Approved
0.6995 Remote Similarity NPD3931 Approved
0.6984 Remote Similarity NPD6590 Discontinued
0.6977 Remote Similarity NPD5257 Clinical (unspecified phase)
0.6974 Remote Similarity NPD5530 Phase 1
0.6961 Remote Similarity NPD5751 Clinical (unspecified phase)
0.6959 Remote Similarity NPD9706 Clinical (unspecified phase)
0.6952 Remote Similarity NPD6281 Approved
0.6946 Remote Similarity NPD3717 Discontinued
0.6944 Remote Similarity NPD9690 Approved
0.6937 Remote Similarity NPD947 Approved
0.6935 Remote Similarity NPD3330 Phase 1
0.6932 Remote Similarity NPD5140 Approved
0.6932 Remote Similarity NPD5138 Approved
0.6931 Remote Similarity NPD8109 Clinical (unspecified phase)
0.6927 Remote Similarity NPD5934 Clinical (unspecified phase)
0.6923 Remote Similarity NPD1620 Clinical (unspecified phase)
0.6914 Remote Similarity NPD9705 Discontinued
0.6914 Remote Similarity NPD112 Approved
0.691 Remote Similarity NPD2844 Phase 3
0.6907 Remote Similarity NPD6975 Discontinued
0.6904 Remote Similarity NPD7671 Approved
0.6904 Remote Similarity NPD7672 Approved
0.6889 Remote Similarity NPD3224 Phase 2
0.6875 Remote Similarity NPD5352 Clinical (unspecified phase)
0.6875 Remote Similarity NPD972 Clinical (unspecified phase)
0.6872 Remote Similarity NPD4724 Clinical (unspecified phase)
0.6872 Remote Similarity NPD6991 Approved
0.6853 Remote Similarity NPD7222 Phase 2
0.6852 Remote Similarity NPD1251 Discontinued
0.6848 Remote Similarity NPD7867 Phase 1
0.6842 Remote Similarity NPD1038 Approved
0.6839 Remote Similarity NPD6026 Approved
0.6831 Remote Similarity NPD5398 Clinical (unspecified phase)
0.6829 Remote Similarity NPD7726 Phase 1
0.6828 Remote Similarity NPD4889 Approved
0.6828 Remote Similarity NPD6227 Discontinued
0.6828 Remote Similarity NPD3082 Discontinued
0.6825 Remote Similarity NPD5912 Clinical (unspecified phase)
0.6825 Remote Similarity NPD5913 Phase 3
0.6818 Remote Similarity NPD9398 Clinical (unspecified phase)
0.6816 Remote Similarity NPD3243 Approved
0.6811 Remote Similarity NPD5596 Phase 2
0.6807 Remote Similarity NPD852 Discontinued
0.6806 Remote Similarity NPD6251 Discontinued
0.6802 Remote Similarity NPD4463 Approved
0.6802 Remote Similarity NPD4462 Approved
0.68 Remote Similarity NPD2581 Approved
0.68 Remote Similarity NPD2582 Approved
0.68 Remote Similarity NPD6220 Phase 3
0.6796 Remote Similarity NPD4112 Clinical (unspecified phase)
0.6791 Remote Similarity NPD5256 Discontinued
0.6789 Remote Similarity NPD3921 Approved
0.6789 Remote Similarity NPD6569 Phase 2
0.6789 Remote Similarity NPD3923 Approved
0.6789 Remote Similarity NPD3922 Approved
0.6789 Remote Similarity NPD3924 Approved
0.6788 Remote Similarity NPD1254 Approved
0.6788 Remote Similarity NPD1253 Approved
0.6788 Remote Similarity NPD1255 Approved
0.6788 Remote Similarity NPD1256 Approved
0.6786 Remote Similarity NPD4886 Phase 2
0.6786 Remote Similarity NPD5020 Approved
0.6771 Remote Similarity NPD5512 Phase 3
0.6771 Remote Similarity NPD6594 Discontinued
0.6768 Remote Similarity NPD5429 Discontinued
0.6766 Remote Similarity NPD2794 Discontinued
0.6765 Remote Similarity NPD1305 Clinical (unspecified phase)
0.6761 Remote Similarity NPD1554 Clinical (unspecified phase)
0.6755 Remote Similarity NPD6141 Clinical (unspecified phase)
0.6754 Remote Similarity NPD9695 Approved
0.6754 Remote Similarity NPD6361 Phase 2
0.6754 Remote Similarity NPD1304 Clinical (unspecified phase)
0.6754 Remote Similarity NPD802 Phase 2
0.6751 Remote Similarity NPD4039 Approved
0.6751 Remote Similarity NPD4034 Approved
0.6751 Remote Similarity NPD4037 Approved
0.6751 Remote Similarity NPD31 Approved
0.6751 Remote Similarity NPD4122 Approved
0.6751 Remote Similarity NPD4795 Phase 2
0.6751 Remote Similarity NPD4038 Approved
0.6751 Remote Similarity NPD4033 Approved
0.6751 Remote Similarity NPD32 Approved
0.6751 Remote Similarity NPD4035 Approved
0.6751 Remote Similarity NPD4036 Approved
0.6749 Remote Similarity NPD6803 Clinical (unspecified phase)
0.6746 Remote Similarity NPD6506 Clinical (unspecified phase)
0.6745 Remote Similarity NPD5040 Clinical (unspecified phase)
0.6738 Remote Similarity NPD6610 Clinical (unspecified phase)
0.6735 Remote Similarity NPD5669 Clinical (unspecified phase)
0.6733 Remote Similarity NPD2616 Phase 3
0.6733 Remote Similarity NPD2615 Phase 3
0.6725 Remote Similarity NPD6148 Clinical (unspecified phase)
0.672 Remote Similarity NPD9714 Clinical (unspecified phase)
0.672 Remote Similarity NPD6965 Clinical (unspecified phase)
0.6718 Remote Similarity NPD1739 Approved
0.6718 Remote Similarity NPD484 Approved
0.6718 Remote Similarity NPD1740 Approved
0.6718 Remote Similarity NPD6389 Clinical (unspecified phase)
0.6717 Remote Similarity NPD4305 Clinical (unspecified phase)
0.6715 Remote Similarity NPD6824 Clinical (unspecified phase)
0.6708 Remote Similarity NPD9284 Approved
0.6708 Remote Similarity NPD9080 Approved
0.6708 Remote Similarity NPD995 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2323 Clinical (unspecified phase)
0.6702 Remote Similarity NPD4375 Approved
0.6701 Remote Similarity NPD7419 Discontinued
0.6685 Remote Similarity NPD4071 Approved
0.6685 Remote Similarity NPD4072 Approved
0.6684 Remote Similarity NPD3127 Clinical (unspecified phase)
0.6683 Remote Similarity NPD7452 Approved
0.6683 Remote Similarity NPD7453 Approved
0.6667 Remote Similarity NPD7112 Discontinued
0.6667 Remote Similarity NPD4551 Phase 2
0.6667 Remote Similarity NPD6138 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5428 Discontinued
0.665 Remote Similarity NPD6208 Discontinued
0.665 Remote Similarity NPD5658 Approved
0.6649 Remote Similarity NPD5003 Discontinued
0.6649 Remote Similarity NPD2952 Discontinued
0.6649 Remote Similarity NPD6630 Clinical (unspecified phase)
0.6648 Remote Similarity NPD5680 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data